These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20717168)

  • 1. Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters.
    Vink JM; van Kemenade FJ; Meijer CJ; Casparie MK; Meijer GA; Boomsma DI
    Eur J Hum Genet; 2011 Jan; 19(1):108-11. PubMed ID: 20717168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.
    Machalek DA; Wark JD; Tabrizi SN; Hopper JL; Bui M; Dite GS; Cornall AM; Pitts M; Gertig D; Erbas B; Garland SM
    Twin Res Hum Genet; 2017 Feb; 20(1):10-18. PubMed ID: 27917752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
    Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
    Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
    Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
    Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer in twins: genetic and nongenetic familial risk factors.
    Ahlbom A; Lichtenstein P; Malmström H; Feychting M; Hemminki K; Pedersen NL
    J Natl Cancer Inst; 1997 Feb; 89(4):287-93. PubMed ID: 9048832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia.
    Huang A; Quinn M; Tan J
    Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):426-8. PubMed ID: 19694701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocervical status is not predictive of the incidence of cervical cancer in the years after negative smears.
    Bos AB; van Ballegooijen M; van den Akker-van Marle ME; Hanselaar AG; van Oortmarssen GJ; Habbema JD
    Am J Clin Pathol; 2001 Jun; 115(6):851-5. PubMed ID: 11392881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study.
    Rebolj M; Helmerhorst T; Habbema D; Looman C; Boer R; van Rosmalen J; van Ballegooijen M
    BMJ; 2012 Oct; 345():e6855. PubMed ID: 23117059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Feasibility of cervical smear in HIV-positive women living in Chad].
    Mortier E; Doudéadoum N; Némian F; Gaulier A; Kemian M
    Bull Soc Pathol Exot; 2016 Aug; 109(3):180-4. PubMed ID: 27299910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.
    Khumthong K; Aue-Aungkul A; Kleebkaow P; Chumworathayi B; Temtanakitpaisan A; Nhokaew W
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2847-2850. PubMed ID: 31554386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and burden in the Dutch cytology-based vs high-risk human papillomavirus-based cervical cancer screening program.
    Loopik DL; Koenjer LM; Siebers AG; Melchers WJG; Bekkers RLM
    Am J Obstet Gynecol; 2021 Feb; 224(2):200.e1-200.e9. PubMed ID: 32800820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pap smear screening in women under 30 in the Norwegian Coordinated Cervical Cancer Screening Program, with a comparison of immediate biopsy vs Pap smear triage of moderate dysplasia.
    Nygård JF; Nygård M; Skare GB; Thoresen SO
    Acta Cytol; 2006; 50(3):295-302. PubMed ID: 16780024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
    Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of cervical smear abnormalities within 3 years of normal cytology.
    Dyson RD
    Obstet Gynecol; 2000 Dec; 96(6):1026. PubMed ID: 11203354
    [No Abstract]   [Full Text] [Related]  

  • 16. Incidence of cervical intraepithelial neoplasia grade III, and cancer of the cervix uteri following a negative Pap-smear in an opportunistic screening.
    Gram IT; Macaluso M; Stalsberg H
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):228-32. PubMed ID: 9512333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical screening: management of patients referred for colposcopy with smear abnormalities less severe than dyskaryosis.
    Usman F; Hammond R
    Cytopathology; 1998 Apr; 9(2):100-6. PubMed ID: 9577736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Genetics to the Susceptibility to Hidradenitis Suppurativa in a Large, Cross-sectional Dutch Twin Cohort.
    van Straalen KR; Prens EP; Willemsen G; Boomsma DI; van der Zee HH
    JAMA Dermatol; 2020 Dec; 156(12):1359-1362. PubMed ID: 33052394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.
    Slimani O; Ben Temim R; Makhlouf T; Mathlouthi N; Attia L
    Tunis Med; 2016 Oct; 94(8-9):616-620. PubMed ID: 28685798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.
    Macgregor JE; Campbell MK; Mann EM; Swanson KY
    BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.